Ruth Matthew R. 4
4 · OPIANT PHARMACEUTICALS, INC. · Filed Sep 1, 2021
Insider Transaction Report
Form 4
Ruth Matthew R.
Chief Commercial Officer
Transactions
- Purchase
Common Stock
2021-08-31$17.34/sh+2,000$34,680→ 17,000 total
4 · OPIANT PHARMACEUTICALS, INC. · Filed Sep 1, 2021
Common Stock